ZURZUVAE DIN 02563541
Status: Approved
Holder: BIOGEN CANADA INC
Health Canada record
| Active ingredient(s) | ZURANOLONE 30 MG |
|---|
| Dosage form | Capsule |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | N06AX31 ZURANOLONE |
|---|
| Original market date | |
|---|
| Current status date | 05-Dec-2025 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Biogen Canada Inc — licence 100797, currently licensed, last inspection rating C (2023-03-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ZURANOLONE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02563525 | ZURZUVAE | BIOGEN CANADA INC | Capsule | ZURANOLONE 20 MG | Marketed |
| 02563533 | ZURZUVAE | BIOGEN CANADA INC | Capsule | ZURANOLONE 25 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 36489 | 2025-12-05 | New Drug Submission (NDS) | |
Request a quote for ZURZUVAE
How to read a Canadian DIN record